The purpose of this study is to evaluate the safety and effectiveness of an investigational, oral drug for celiac disease to see if it can reduce the symptoms of celiac disease (such as abdominal pain, bloating, cramping, and gas) as compared to a placebo.
Duration: Approximately 30 weeks
Number of visits to AMR Lexington: 8
Reimbursement: Up to $1,024 for time and travel.
NOTE: Qualified participants must be at least 18 years of age, have been formally diagnosed by a physician as having celiac disease for at least the past 6 months, and have persistent Celiac symptoms despite following a gluten-free diet for at least 6 consecutive months. Other criteria also apply
If you are interested in participating in this study, please fill out the form below. This will help us determine if you meet some of the initial criteria necessary to participate. We will contact you within 48 hours to follow up and clarify any questions that you, or we, may have. The information you provide is entered in our secure, password protected database which can only be accessed by authorized AMR Lexington personnel, unless given your permission or except as required by law. The provided information will only be used to contact you to tell you more about this and any future study. Your contact information will remain within our database indefinitely unless otherwise requested.
By submitting this information, AMR Lexington has my permission to contact me. My consent allows AMR Lexington to use phone, text and email messages to contact me. Message and data rates may apply. I may contact AMR Lexington any time to change these preferences. To be removed or to change your contact preferences, please call an AMR Lexington recruitment specialist at 859-264-8999.